Insulin Resistance Directly Contributes to Androgenic Potential Within Ovarian Theca Cells

Fertility and Sterility

Volumn 91, Issue 5 SUPPL., 2009, Pages 1990-1997

  Qu, JunWei ^a   Wang, Yong ^a,b   Wu, Xiaoke ^b   Gao, Lei ^b   Hou, Lihui ^b   Erkkola, Risto ^c  

^a NANJING UNIVERSITY   (China)

^b University Infertility Centre   (China)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Insulin resistance; insulin sensitizers; ovarian theca cells; PCOS

Indexed keywords

DEXAMETHASONE; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR SUBSTRATE 1; INSULIN SENSITIZING AGENT; MESSENGER RNA; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROID 17ALPHA MONOOXYGENASE; TESTOSTERONE; TROGLITAZONE;

ANDROGEN SYNTHESIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE EXPRESSION; GLUCOSE TRANSPORT; HYPERANDROGENISM; INSULIN RESISTANCE; NONHUMAN; OVARY CELL CULTURE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; SWINE; THECA CELL; WESTERN BLOTTING;

ANDROGENS; ANIMALS; CELL CULTURE TECHNIQUES; CHROMANS; FEMALE; GLUCOSE TRANSPORTER TYPE 4; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; METFORMIN; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROID 17-ALPHA-HYDROXYLASE; SWINE; THECA CELLS; THIAZOLIDINEDIONES;

EID: 67349094282     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.02.167     Document Type: Article

References (27)

1. Zhao J., Chen Z., and Zhao L. Epidemiological study of clinical characteristics of Chinese Han ethnic women with polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi 41 (2006) 375-379
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
3. Yu Q. A specialists' consensus on the diagnosis and treatment of Chinese women with polycystic ovary syndrome. Zhongguo Shiyong Fu Chan Ke Za Zhi 32 (2007) 474
4. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18 (1997) 774-800
5. Corbould A., Zhao H., Mirzoeva S., Aird F., and Dunaif A. Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome. Diabetes 55 (2006) 751-759
6. Book C.B., and Dunaif A. Selective IR in the polycystic ovary syndrome. J Clin Endocrinol Metab 84 (1999) 3110-3116
7. Rosenbaum D., Haber R.S., and Dunaif A. Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am J Physiol 264 (1993) E197-E202
8. Dunaif A., Segal K.R., Shelley D.R., Green G., Dobrjansky A., and Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41 (1992) 1257-1266
9. Wang X.B., Hou L.H., and Wu X.K. The historic origin of diagnosis and treatment of menstrual disorders by concept of "phlegm" in traditional Chinese medicine. Zhongguo Zongyi Jichu Yixue Za Zhi 13 (2007) 497-499
10. Wu X.K., Zhou S.Y., Liu J.X., Pöllänen P., Sallinen K., Mäkinen M., et al. Selective ovarian resistance to insulin signaling in women with polycystic ovary syndrome. Fertil Steril 80 (2003) 954-965
11. Wu X., Sallinen K., Anttila L., Mäkinen M., Luo C., Pöllänen P., et al. Expression of insulin-receptor substrate-1 and -2 in ovaries from women with IR and from controls. Fertil Steril 74 (2000) 564-572
12. Yildiz B.O., Yarali H., Oguz H., and Bayraktar M. Glucose intolerance, IR, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 88 (2003) 2031-2036
13. Dallman M.F., Akana S.F., Pecoraro N.C., Warne J.P., la Fleur S.E., and Foster M.T. Glucocorticoids, the etiology of obesity and the metabolic syndrome. Curr Alzheimer Res 4 (2007) 199-204
14. Kaltsas G.A., Isidori A.M., Besser G.M., and Grossman A.B. Secondary forms of polycystic ovary syndrome. Trends Endocrinol Metab 15 (2004) 204-210
15. Willi S.M., Kennedy A., Wallace P., Ganaway E., Rogers N.L., and Garvey W.T. Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin. Diabetes 51 (2002) 2895-2902
16. Caperuto L.C., Anhê G.F., Amanso A.M., Ribeiro L.M., Medina M.C., Souza L.C., et al. Distinct regulation of IRS proteins in adipose tissue from obese aged and Dex-treated rats. Endocrine 29 (2006) 391-398
17. Anil Kumar K.L., and Marita A.R. Troglitazone prevents and reverses dexamethasone induced IR on glycogen synthesis in 3T3 adipocytes. Br J Pharmacol 130 (2000) 351-358
18. Schoppee P.D., Garmey J.C., and Veldhuis J.D. Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. Biol Reprod 66 (2002) 190-198
19. Attia G.R., Rainey W.E., and Carr B.R. Metformin directly inhibits androgen production in human theca cells. Fertil Steril 76 (2001) 517-524
20. Magoffin D.A., and Erickson G.F. Purification of ovarian theca-interstitial cells by density gradient centrifugation. Endocrinology 122 (1988) 2345-2347
21. Zhang G., Garmey J.C., and Veldhuis J.D. Interactive stimulation by luteinizing hormone and insulin of the steroidogenic acute regulatory (StAR) protein and 17α-hydroxylase/17,20-lyase (CYP17) genes in porcine theca cells. Endocrinology 141 (2000) 2735-2742
22. Berger J., Bailey P., Biswas C., Cullinan C.A., Doebber T.W., Hayes N.S., et al. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137 (1996) 4189-4195
23. Lin Y., Fridström M., and Hillensjö T. Insulin stimulation of lactate accumulation in isolated human granulosa-luteal cells: a comparison between normal and polycystic ovaries. Hum Reprod 12 (1997) 2469-2472
24. Moran C., Huerta R., Conway-Myers B.A., Hines G.A., and Azziz R. Altered autophosphorylation of the insulin receptor in the ovary of a woman with polycystic ovary syndrome. Fertil Steril 75 (2001) 625-628
25. Baillargeon J.P., and Nestler J.E. Polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?. J Clin Endocrinol Metab 1 (2006) 22-28
26. Montagnani M., Golovchenko I., Kim I., Koh G.Y., Goalstone M.L., Mundhekar A.N., et al. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 277 (2002) 1794-1799
27. Komar C.M. Peroxisome proliferator-activated receptors (PPARs) and ovarian function-implications for regulating steroidogenesis, differentiation, and tissue remodeling. Reprod Biol Endocrinol 3 (2005) 41-55